Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fat Cats are back on?

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Feb 02, 2022 5:48pm

124 Views

Post# 34391031

RE:RE:RE:RE:RE:RE:RE:Fat Cats are back on?

So thanks for the dietary health lecture. Tremendous value added to the discussion.

But you did inadvertently point something out. That is why the diet industry is hundreds of billions large in market size.

Morons and non morons create wealth opportunities with their inadequacy. Who cares, there is a gap in what the market offers, and it gets filled by the best contenders.

I am not that picky on how money gets made. Its a massive market and if they do a deal, then we get the gold.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario